Fast Five Quiz: Interstitial Lung Disease Progressive Fibrosing Management

Zab Mosenifar, MD


February 01, 2022

In the setting of PF-ILDs, determining a specific diagnosis within this group of diseases (disease splitting) is important early in patient management. This is because the early phase of PF-ILD is specific to each disease subtype. On the other hand, due to similar clinical behavior and common underlying pathogenic mechanisms, treatment of PF-ILDs may be "lumped" together in late stages, when the diseases share a self-perpetuating fibrosis mechanism.

Learn more about the treatment of PF-ILD.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.